Verobioscience

Vero Bioscience measures biological age at the organ level using advanced proteomics and machine learning. Its OrganAge test analyzes thousands of proteins from a single blood draw to detect the earliest molecular signs of organ-specific aging, enabling targeted interventions to slow or reverse the aging process. The company is a Khosla Ventures-backed longevity and diagnostics startup whose work has been published in Nature and Nature Medicine. As of this enrichment pass Vero Bioscience operates a consumer waitlist and partnership program and exposes no public developer API, documentation portal, or SDK surface.

Verobioscience is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Proteomics, Longevity, and Aging.

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
AccessApproval
0 APIs
CompanyBiotechnologyProteomicsLongevityAgingDiagnosticsHealthMachine Learning

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/verobioscience: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Verobioscience Domain Security

TLSv1.3 · DNSSEC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: verobioscience
accessModel:
  pricing: unknown
  onboarding: approval
  trial: false
  try_now: false
  public: false
  label: Requires approval
  confidence: medium
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/verobioscience.png
name: Verobioscience
description: Vero Bioscience measures biological age at the organ level using advanced proteomics and machine learning. Its
  OrganAge test analyzes thousands of proteins from a single blood draw to detect the earliest molecular signs of organ-specific
  aging, enabling targeted interventions to slow or reverse the aging process. The company is a Khosla Ventures-backed longevity
  and diagnostics startup whose work has been published in Nature and Nature Medicine. As of this enrichment pass Vero Bioscience
  operates a consumer waitlist and partnership program and exposes no public developer API, documentation portal, or SDK surface.
url: https://raw.githubusercontent.com/api-evangelist/verobioscience/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- khosla-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Proteomics
- Longevity
- Aging
- Diagnostics
- Health
- Machine Learning
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1
common:
- type: DomainSecurity
  url: security/verobioscience-domain-security.yml
- type: Website
  url: https://www.verobioscience.com/